Cover Image
市場調查報告書

全球藥物遞輸市場:經皮吸收技術及吸入技術

Global Markets for Drug Delivery: Transdermal and Inhalation Drug Delivery Technologies in 2015

出版商 Life Science Intelligence, Inc. 商品編碼 338586
出版日期 內容資訊 英文 106 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球藥物遞輸市場:經皮吸收技術及吸入技術 Global Markets for Drug Delivery: Transdermal and Inhalation Drug Delivery Technologies in 2015
出版日期: 2015年09月01日 內容資訊: 英文 106 Pages
簡介

本報告提供全球經皮吸收型藥物遞輸技術及吸入型給藥技術的市場相關調查、技術、產品種類與概要、患者數及市場規模的變化與預測、各地區的明細、競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 摘要整理

  • 美國
  • 歐洲
  • 亞太地區、其他地區
  • 競爭分析

第2章 經皮吸收技術及吸入技術

  • 經皮吸收技術
    • 離子電滲
    • 貼片
    • 微針頭
  • 吸入設備
    • 乾粉吸入劑
    • 計量吸入器
    • 噴霧器
    • 產品、供應商

第3章 經皮吸收型及吸入型給藥技術:全球市場分析

  • 經皮吸收型藥物遞輸技術的患者數、市場預測:各地區
    • 美國
      • 心血管系統
      • 荷爾蒙補充
      • 神經/精神醫學
      • 疼痛管理
      • 避孕
      • 戒煙
      • 泌尿器官系統
      • 離子電滲
      • 供應商的佔有率
    • 歐洲
    • 亞太地區、其他地區
  • 吸入型給藥技術的患者數、市場預測:各地區
    • 美國
      • 競爭分析
    • 歐洲
    • 亞太地區、其他地區
    • 競爭分析

第4章 企業簡介

  • 3M Health Care
  • Actavis (Allergan)
  • CareFusion
  • DJO Global
  • DeVilbiss Healthcare
  • GlaxoSmithKline
  • Johnson & Johnson
  • Monaghan Medical
  • Mylan
  • Novartis
  • Noven Pharmaceuticals (久光製藥)
  • Philips Healthcare
  • Salter Labs
  • Smiths Medical
  • Somerset Pharmaceuticals
  • 帝國製藥
  • Teleflex Medical
  • UCB
目錄

A new report from LSI, "Global Markets for Drug Delivery: Transdermal and Inhalation Drug Delivery Technologies in 2015," explores the dynamic market for transdermal drug patches, iontophoresis devices, dry powder inhalers, metered dose inhalers, and nebulizers. The market, which was valued at $8.2 billion in 2014, is being driven by powerful regional and economic forces; key among these are the introduction and adoption of generic products, rising caseloads, the pursuit of new and expanded therapeutic indications, and the state of healthcare development in important national markets. This report-which provides detailed forecasts for product segments, clinical caseloads, and global regions-analyzes the impacts these factors will have through 2020, examines competitive market shares, and highlights the main forces driving and limiting growth in the global market.

Critical Issues Covered in this Report:

  • The competitive landscape for transdermal drug delivery and inhalation devices in the U.S. and international markets;
  • Revenues for key components and devices; and
  • Key caseloads for transdermal drug applications.

Table of Contents

1. EXECUTIVE SUMMARY

  • 1.1 The United States
  • 1.2 Europe
  • 1.3 Asia-Pacific and the Rest of the World
  • 1.4 Competitive Analysis
  • Exhibit 1-1: Global Market Forecast for Transdermal and Inhalation Drug Delivery Technologies by Product Type, 2013-2020
  • Exhibit 1-2: Global Market Forecast for Transdermal and Inhalation Drug Delivery Technologies by Region, 2013-2020
  • Exhibit 1-3: U.S. Market Forecast for Transdermal and Inhalation Drug Delivery Technologies by Product Type, 2013-2020
  • Exhibit 1-4: European Market Forecast for Transdermal and Inhalation Drug Delivery Technologies by Product Type, 2013-2020
  • Exhibit 1-5: AP & ROW Market Forecast for Transdermal and Inhalation Drug Delivery Technologies by Product Type, 2013-2020
  • Exhibit 1-6: Global Supplier Shares in 2013 and 2014

2. TRANSDERMAL AND INHALATION TECHNOLOGIES

  • 2.1 Transdermal Technologies
    • 2.1.1 Iontophoresis
    • 2.1.2 Patches
    • 2.1.3 Microneedles
  • 2.2 Inhalation Devices
    • 2.2.1 Dry Powder Inhalers
    • 2.2.2 Metered Dose Inhalers
    • 2.2.3 Nebulizers
    • 2.2.4 Products and Suppliers
  • Exhibit 2-1: Overview of Transdermal and Inhalation Drug Delivery Technologies
  • Exhibit 2-2: Transdermal Technologies by Type
  • Exhibit 2-3: Transdermal Drug Delivery Technologies: Selected Products and Suppliers in 2015
  • Exhibit 2-4: Inhalation Technologies by Type
  • Exhibit 2-5: Inhalation Devices: Selected Products and Suppliers in 2015

3. TRANSDERMAL AND INHALATION DRUG DELIVERY TECHNOLOGIES: GLOBAL MARKET ANALYSIS

  • 3.1 Patient Volumes and Market Forecasts: Transdermal Drug Delivery Technologies by Region
    • 3.1.1 The United States
      • 3.1.1.1 Cardiovascular
      • 3.1.1.2 Hormone Replacement
      • 3.1.1.3 Neurological/Psychiatric
      • 3.1.1.4 Pain Management
      • 3.1.1.5 Pregnancy Prevention
      • 3.1.1.6 Smoking Cessation
      • 3.1.1.7 Urology
      • 3.1.1.8 Iontophoresis
      • 3.1.1.9 Supplier Shares
    • 3.1.2 Europe
    • 3.1.3 Asia-Pacific and the Rest of the World
  • 3.2 Patient Volumes and Market Forecasts: Inhalation Drug Delivery Technologies by Region
    • 3.2.1 The United States
      • 3.2.1.1 Competitive Analysis
    • 3.2.2 Europe
    • 3.2.3 Asia-Pacific and the Rest-of-the-World
    • 3.2.4 Competitive Analysis
  • Exhibit 3-1: Global Market Forecast for Transdermal and Inhalation Drug Delivery Technologies by Region, 2013-2020
  • Exhibit 3-2: Global Market Forecast for Transdermal and Inhalation Drug Delivery Technologies by Product Type, 2013-2020
  • Exhibit 3-3: U.S. Market Forecast for Transdermal Drug Delivery Technologies: Iontophoresis and Transdermal Patches, 2013-2020
  • Exhibit 3-4: Key Caseloads for Transdermal Patches in the U.S., 2013-2020
  • Exhibit 3-5: U.S. Market Forecast for Transdermal Patches by Category, 2013-2020
  • Exhibit 3-6: U.S. Market Forecast for Transdermal Patches by Application, 2013-2020
  • Exhibit 3-7: U.S. Market Forecast for Iontophoresis Devices, 2013-2020
  • Exhibit 3-8: U.S. Supplier Shares, Transdermal Drug Delivery Technologies, 2013 and 2014
  • Exhibit 3-9: European Market Forecast for Transdermal Drug Delivery Technologies: Iontophoresis and Transdermal Patches, 2013-2020
  • Exhibit 3-10: Key Caseloads for Transdermal Patches in Europe, 2013-2020
  • Exhibit 3-11: European Market Forecast for Transdermal Patches by Category, 2013-2020
  • Exhibit 3-12: European Market Forecast for Transdermal Patches by Application, 2013-2020
  • Exhibit 3-13: European Market Forecast for Iontophoresis Devices, 2013-2020
  • Exhibit 3-14: AP & ROW Market Forecast for Transdermal Drug Delivery Technologies: Iontophoresis and Transdermal Patches, 2013-2020
  • Exhibit 3-15: Key Caseloads for Transdermal Patches in AP & ROW Countries, 2013-2020
  • Exhibit 3-16: AP & ROW Market Forecast for Transdermal Patches by Category, 2013-2020
  • Exhibit 3-17: AP & ROW Market Forecast for Transdermal Patches by Application, 2013-2020
  • Exhibit 3-18: AP & ROW Market Forecast for Iontophoresis Devices, 2013-2020
  • Exhibit 3-19: OUS Supplier Shares, Transdermal Drug Delivery Technologies, 2013 and 2014
  • Exhibit 3-20: U.S. Market Forecast for Inhalation Technologies by Type, 2013-2020
  • Exhibit 3-21: U.S. Market Forecast for Dry Powder Inhalers, 2013-2020
  • Exhibit 3-22: U.S. Market Forecast for Metered Dose Inhalers, 2013-2020
  • Exhibit 3-23: U.S. Market Forecast for Nebulizers, 2013-2020
  • Exhibit 3-24: U.S. Supplier Shares, Inhalation Technologies, 2013 and 2014
  • Exhibit 3-25: European Market Forecast for Inhalation Technologies by Type, 2013-2020
  • Exhibit 3-26: European Market Forecast for Dry Powder Inhalers, 2013-2020
  • Exhibit 3-27: European Market Forecast for Metered Dose Inhalers, 2013-2020
  • Exhibit 3-28: European Market Forecast for Nebulizers, 2013-2020
  • Exhibit 3-29: AP & ROW Market Forecast for Inhalation Technologies by Type, 2013-2020
  • Exhibit 3-30: AP & ROW Market Forecast for Dry Powder Inhalers, 2013-2020
  • Exhibit 3-31: AP & ROW Market Forecast for Metered Dose Inhalers, 2013-2020
  • Exhibit 3-32: AP & ROW Market Forecast for Nebulizers, 2013-2020
  • Exhibit 3-33: OUS Supplier Shares, Inhalation Technologies, 2013 and 2014

4. COMPANY PROFILES

  • 4.1 3M Health Care
  • 4.2 Actavis (Allergan)
  • 4.3 CareFusion
  • 4.4 DJO Global
  • 4.5 DeVilbiss Healthcare
  • 4.6 GlaxoSmithKline
  • 4.7 Johnson & Johnson
  • 4.8 Monaghan Medical
  • 4.9 Mylan
  • 4.10 Novartis
  • 4.11 Noven Pharmaceuticals (Hisamitsu Pharmaceutical)
  • 4.12 Philips Healthcare
  • 4.13 Salter Labs
  • 4.14 Smiths Medical
  • 4.15 Somerset Pharmaceuticals
  • 4.16 Teikoku Pharma
  • 4.17 Teleflex Medical
  • 4.18 UCB
Back to Top